Inventiva (IVA) Long-Term Investments (2023 - 2025)
Inventiva (IVA) posted quarterly Long-Term Investments of $275.3 million for Q4 2025, up 157.31% year-over-year from $107.0 million in Q4 2024, and down 70.87% quarter-over-quarter from $945.2 million in Q2 2025.
Analysis
Inventiva (IVA) Long-Term Investments (2023 - 2025) Analysis & Trends
Inventiva's Long-Term Investments history runs 8 years deep, the most recent figure standing at $275.3 million for Q4 2025.
- In Q4 2025, Long-Term Investments rose 157.31% year-over-year to $275.3 million; the TTM figure through Dec 2025 stood at $275.3 million (up 157.31% YoY), while the FY2025 annual figure was $275.3 million, up 157.31% from the prior year.
- Long-Term Investments for Q4 2025 stood at $275.3 million, down from $945.2 million in the prior quarter.
- The five-year high for Long-Term Investments was $945.2 million in Q2 2025, with the low at $955015.7 in Q2 2022.
- The 5-year median for Long-Term Investments is $68.4 million (2023), against an average of $161.0 million.
- The sharpest annual moves came in 2023 and 2025: Long-Term Investments sank 51.14% in 2023, then surged 4055.39% in 2025.
- Inventiva's Long-Term Investments stood at $117.8 million in 2021, then decreased by 22.04% to $91.8 million in 2022, then tumbled by 51.14% to $44.9 million in 2023, then soared by 138.42% to $107.0 million in 2024, then surged by 157.31% to $275.3 million in 2025.
- Business Quant data shows IVA's Long-Term Investments at $275.3 million in Q4 2025, $945.2 million in Q2 2025, and $107.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -4.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1.77 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 372.10 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | 613,450.93 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 613,450.93 |
| Jun 30, 2025 | 945,186.34 |
| Dec 31, 2024 | 1.22 Mn |
| Jun 30, 2024 | 22.75 Mn |
| Dec 31, 2023 | 1.53 Mn |